Protracted coronavirus disease 2019 after chimeric antigen receptor-T cell therapy successfully treated with sequential multidrug therapy

MLA

Masahiro Yamashita, et al. “Protracted Coronavirus Disease 2019 after Chimeric Antigen Receptor-T Cell Therapy Successfully Treated with Sequential Multidrug Therapy.” Respiratory Medicine Case Reports, vol. 51, no. 102104-, Jan. 2024. EBSCOhost, https://doi.org/10.1016/j.rmcr.2024.102104.

APA

Masahiro Yamashita, Hisao Higo, Nobuharu Fujii, Chiaki Matsumoto, Go Makimoto, Kiichiro Ninomiya, Masanori Fujii, Kammei Rai, Eiki Ichihara, Kadoaki Ohashi, Katsuyuki Hotta, Masahiro Tabata, Yoshinobu Maeda, & Nobuaki Miyahara. (2024). Protracted coronavirus disease 2019 after chimeric antigen receptor-T cell therapy successfully treated with sequential multidrug therapy. Respiratory Medicine Case Reports, 51(102104-). https://doi.org/10.1016/j.rmcr.2024.102104

Chicago

Masahiro Yamashita, Hisao Higo, Nobuharu Fujii, Chiaki Matsumoto, Go Makimoto, Kiichiro Ninomiya, Masanori Fujii, et al. 2024. “Protracted Coronavirus Disease 2019 after Chimeric Antigen Receptor-T Cell Therapy Successfully Treated with Sequential Multidrug Therapy.” Respiratory Medicine Case Reports 51 (102104-). doi:10.1016/j.rmcr.2024.102104.